Financial Data and Key Metrics - The company achieved a net profit of 13.2millionandadjustedEBITDAof29 million in Q3 2024, marking a historic milestone [8] - Revenue for Q3 2024 reached 101.4million,a2780.1 million in Q3 2023 [21] - Gross margin improved to 33.2%, up 10.9 percentage points year-over-year [21] - Adjusted gross margin rose to 33.9%, a 9.7 percentage point increase compared to the prior year period [22] - Operating expenses decreased by 38% to 27.5millioninQ32024from44.7 million in Q3 2023 [24] - Adjusted operating expenses were 22millioninQ32024,down8.4 million from 30.3millioninQ32023[25]BusinessLineDataandKeyMetrics−TheEMEAregionsawa21290 million to $95 million, with full-year revenue growth anticipated at 15% to 18% [32] - The company is targeting sustained positive adjusted EBITDA contributions from its established business in EMEA and APAC [34] - Microvast is focused on product development, operational efficiencies, key customer growth, reducing liabilities, and strategic cost-cutting [35] Other Important Information - The company holds more than 775 patents, either granted or pending, with products powering equipment worldwide [37] - Microvast unveiled new cell technologies leveraging silicon at IAA 2024 in Germany, providing improved energy density for high-performance applications [39] Q&A Session - No Q&A session was recorded in the provided document [39]